Christian Hendershot
Christian Hendershot is a clinical research director at the University of Southern California's Institute for Addiction Research. Recently, he gained attention for his work on a study published in JAMA Psychiatry, which demonstrated that the medication semaglutide, commonly known through the brand Ozempic, can significantly reduce alcohol consumption among individuals struggling with alcohol use disorders.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Liechtenstein:
Christian Hendershot is the director of clinical research at the University of Southern California and the lead author of the study.
7
Paraguay:
Christian Hendershot is the director of Clinical Research at the University of Southern California's Addiction Research Institute.
9